United Guardian Inc (UG) stock
Close on Nov 12, 2026Market cap $39.65MP/E 12.7Yield –
United Guardian Inc grew revenue 23.6% to $12.44M over the twelve months to Sep 30, 2026. Operating income rose 55.3% to $3.23M, moving the operating margin from 20.7% to 25.9%. Free cash flow was $2.94M, up 89.3% from a year earlier. At the latest close the market valued the company at $39.65M, 12.7 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $39.65M
- P/E ratio
- 12.7
- Price to sales
- 3.19
- Price to book
- 3.55
- Dividend yield
- –
- Free cash flow yield
- 7.42%
Fundamentals
- Revenue
- $12.44M
- Net income
- $3.13M
- EPS, diluted
- $0.68
- Free cash flow
- $2.94M
- Book value per share
- $2.43
- Diluted shares
- 5M
Trading
- Next earnings
- Mar 26, 2027 (estimated, before the open)
- Previous close
- $8.59
- Open
- $8.98
- Day's range
- $8.37 – $9.48
- Volume
- 20,380
- Average volume (20 days)
- 21,587
- Beta (5 years)
- 0.54
- 52-week range
- $5.58 – $9.95
- RSI (14 days)
- 68.3
- Volatility (1 year)
- 45.7%
- Relative volume
- 1.67×
- WACC
- 7.7%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | UG | S&P 500 | Difference | UG per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +25.1% | -2.7% | +27.8 pts | ||
| 3 months | +19.0% | -1.7% | +20.8 pts | ||
| Year to date | +50.7% | +11.9% | +38.8 pts | ||
| 1 year | +51.2% | +12.0% | +39.2 pts | ||
| 3 years | +46.9% | +78.2% | −31.3 pts | +13.7% | +21.2% |
| 5 years | -19.0% | +73.2% | −92.3 pts | -4.1% | +11.6% |
| 10 years | -4.8% | +309.6% | −314.5 pts | -0.5% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases United Guardian filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Update
- Results
- Results
- Update
About United Guardian
Perfumes, Cosmetics & Other Toilet Preparations
United-Guardian, Inc., operating through its Guardian Laboratories division, develops, manufactures, and markets specialty ingredients and healthcare products. Its offerings comprise cosmetic ingredients, medical lubricants, pharmaceutical products, and sexual wellness ingredients. The company produces hydrogel formulations under the Lubrajel brand for cosmetic and medical applications, including catheter lubrication and oral care, alongside natural cosmetic lines certified to organic standards. Its pharmaceutical line includes Renacidin, an FDA-approved prescription drug used to prevent and dissolve catheter calcifications, and Clorpactin, a topical antimicrobial. United-Guardian sells its cosmetic ingredients globally through commercial distributors and supplies its medical lubricants directly to medical device manufacturers. It distributes its prescription drugs within the United States primarily through national drug wholesalers supplying hospitals and pharmacies.
Company profile, executives and historyUnited Guardian stock: common questions
What is United Guardian's stock price?
UG closed at $8.63 on Nov 12, 2026, up 0.47% on the day. Over the past 52 weeks it traded between $5.58 and $9.95.
What is United Guardian's market cap?
United Guardian was worth $39.65M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is UG's P/E ratio?
UG trades at 12.7 times earnings, based on diluted earnings per share of $0.68 over the twelve months to Sep 30, 2026.
How much revenue does United Guardian make?
United Guardian reported revenue of $12.44M for the twelve months to Sep 30, 2026, up 23.6% from a year earlier.
Does United Guardian pay a dividend?
No. United Guardian has not paid a cash dividend over the last twelve months.
When does United Guardian report earnings next?
United Guardian is expected to report Q4 FY2026 results on Mar 26, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has UG stock performed over the past year?
Including dividends, UG returned +51.2% over the past year, against +12.0% for the S&P 500.
How many UG shares are sold short?
0M shares were sold short at the latest FINRA report, 0.39% of the float, or 1.0 days of average trading volume.
Who are United Guardian's competitors?
Companies most similar to United Guardian by business, industry and size include YCBD, CSCIF, SLSN, AXIL, DQWS.
See a number that looks wrong?